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Chronic non-specific lung disease (CNSLD) encompasses asthma as well as chronic obstructive 
pulmonary disease (COPD). Recently in health care, there has been increasing awareness in the 
functional, psychological and social aspects of the health of patients; their quality of life (QOL). 
Quality-of-life research addressing CNSLD patients has been rather underdeveloped for a long period of 
time. Recently, however, the importance of QOL is being increasingly recognized, and several research 
groups have started to study QOL in CNSLD patients in more detail. 
This paper describes the construction of a disease-specific QOL instrument for patients with mild to 
moderately severe CNSLD. Items relating to several domains of QOL were listed, and 171 CNSLD 
patients in general practice were asked how much of a problem each item had been (assessed on a 
seven-point Likert scale). After applying an item-selection procedure, a uni-dimensional QOL question- 
naire was constructed consisting of 55 items divided into seven domain subscales: breathing problems, 
physical problems, emotions, situations triggering or enhancing breathing problems, general activities, 
daily and domestic activities, and social activities, relationships and sexuality. Reliability estimates of the 
domain subscales of the constructed questionnaire varied from 0.68 to 0.89, and was 0.92 for the QOL 
for Respiratory Illness Questionnaire (QOL-RIQ) total scale. A first impression of the construct validity 
of the questionnaire was gained by investigation of the relationship between the QOL domain subscales 
and several indicators of illness severity, as well as the relative contribution of illness severity variables, 
background characteristics and symptoms to QOL, using regression analysis. Further research to 
validate the questionnaire to a greater extent (construct validity, test-retest reliability and responsiveness 
to change) is currently taking place. 
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Introduction 
Chronic non-specific lung disease (CNSLD) 
encompasses asthma, chronic bronchitis and 
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emphysema. All three illnesses concern chronic 
ailments of the airways where the patient has, for 
a short or long time, suffered from shortness of 
breath. In general, asthmatic patients only have 
breathing problems occasionally and/or over 
short periods of time, whereas for patients with 
chronic bronchitis or emphysema [chronic 
obstructive pulmonary disease (COPD)], breath- 
ing problems are a constant problem (1,2). These 
chronic diseases have a prevalence of lo-20%. 
y, 1997 W. B. SAUNDERS COMPANY LTD 
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Despite the introduction of new treatment 
modalities, CNSLD is responsible for a con- 
siderable and rising percentage of the morbidity 
and mortality in Western countries (3-7). Not 
only is CNSLD a medical-biological problem, 
but it also affects the perceived psychological 
and social health of patients. 
In the past, various studies have established 
that CNSLD has great consequences on the 
daily functioning of the patient. As well as 
symptoms such as breathing problems, cough- 
ing, allergic reactions etc., which arise directly 
from the disorder, fatigue, sleeping difficulties 
and limitations in physical and daily activities 
have also been identified as consequences of 
CNSLD (8-11). A variety of emotional prob- 
lems result from CNSLD, such as fear, shame, 
helplessness, dependence and depression (12- 
14). Chronic non-specific lung disease can also 
have many effects on relationships and social 
contacts; social isolation and loneliness are often 
cited (15,16). Most of the studies mentioned 
above have not had the investigation of the QOL 
of the patients as their main objective. They 
have, therefore, frequently examined parts of 
daily functioning alone (17). 
In recent years, it has been increasingly recog- 
nized that the evaluation of health care should 
also include outcomes important to patients, 
such as QOL (18). As a result, there has been 
increasing awareness in the functional, emo- 
tional and social aspects of the health of 
patients, in addition to the usual regard for 
conventional relief-giving expedients such as 
those which slow down the progress of illness or 
bring physical symptoms under control (19). 
Indeed, where decisions about the consequences 
of medical treatments and care of the chronically 
ill are concerned, the QOL of the patient has 
become an important measure in health care. 
Although the term ‘QOL’ is not unequivocally 
defined, it is generally assumed that a good 
approximation is provided by questionnaires 
which deal with at least the following areas of 
daily life: physical and functional status, psycho- 
logical status and social functioning (19,20). 
With regard to assessing QOL, a distinction is 
generally made between ‘generic’ and ‘disease- 
specific’ questionnaires. Generic instruments 
measure general characteristics and conse- 
quences of sickness, and have the advantage of 
being broadly applicable to people with different 
disorders. They also make possible mutual com- 
parisons between individuals or groups with 
different illnesses. However, to take into account 
the characteristic problems and consequences for 
daily functioning of specific disorders, disease- 
specific questionnaires are being used with 
increasing frequency. Quality-of-life research on 
CNSLD has been rather underdeveloped for a 
long period of time (17). This subject was con- 
sidered to be one of the most important areas for 
future CNSLD research by Dutch medical and 
behavioural science experts in 199 1 (21,22). At 
that time, the only questionnaire that existed for 
research in this area was the Chronic Respirat- 
ory Disease Questionnaire of Guyatt et al. (8), 
developed for patients with chronic bronchitis 
and emphysema (23). 
Prompted by developments in the area of 
QOL in health care, and the need for the devel- 
opment of a questionnaire in the Dutch language 
for CNSLD patients (21), the present authors 
decided to develop a disease-specific question- 
naire which included functional, psychological 
and social aspects of the QOL of CNSLD 
patients. In The Netherlands, 80% of the diag- 
nosed CNSLD patients are treated by general 
practitioners (GPs) (5,24). Chronic non-specific 
lung disease patients in a GP setting are obvi- 
ously more troubled in their daily activities than 
a healthy population (25); however, relatively 
little research has been done into the conse- 
quences of mild and moderately severe CNSLD 
on daily functioning (17). Therefore, the authors 
decided to address patients with asthma and 
COPD from GP settings (26,27). 
In this article, the first stage of this project is 
described; the construction of a disease-specific 
QOL questionnaire for patients with asthma or 
COPD in general practice. The question- 
naire itself is presented as well as some of its 
psychometric qualities. 
Methods 
ITEM SELECTION 
The development of the questionnaire was 
guided by two principles: (i) the statement of 
Spilker (19) that questionnaires on QOL should 
at least include the areas of physical and 
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functional status, psychological status and social 
functioning; and (ii) the stages in development of 
QOL questionnaires described by Guyatt et al. 
v3). 
Based on a study of the literature, other 
generic QOL questionnaires, consultations with 
people providing medical care for CNSLD 
patients, and consultations with foreign experts 
in the area of QOL and CNSLD (Guyatt and 
Juniper), a questionnaire was developed with a 
large number of items. This questionnaire was as 
broad and as comprehensive as possible, the aim 
being to reduce and modify it according to the 
responses from a large number of CNSLD 
patients. 
First, to check for completeness and clarity, 
the formulated items were put to 11 CNSLD 
patients in a semi-structured interview. From 
this, items were supplemented and the ques- 
tionnaire was modified. To achieve content 
validity, items were grouped into subscales on 
the basis of their apparent content (29). This 
resulted in a questionnaire containing 221 items 
on the following topics: breathing problems (14 
items); other physical problems related to 
CNSLD (29 items); situations and/or sub- 
stances that can trigger or enhance breathing 
problems (22 items); other problems related to, 
the treatment of, CNSLD, i.e. financial prob- 
lems (16 items); emotions relating to breathing 
problems (47 items); general activities (19 
items); daily and domestic activities (19 
items); sport, hobbies and leisure pursuits (12 
items); social activities (11 items); sexuality 
and relationships (eight items); profession and 
work (15 items); and schooling/training (nine 
items). 
PATIENT SELECTION 
For the benefit of the item-reduction phase, 14 
GPs in the Western region of The Netherlands, 
including rural as well as urban settings, selected 
a total of 219 CNSLD patients in the age group 
of 18-65 years. In all cases, the GP was the main 
caregiver. Patients with diabetes, rheumatic dis- 
eases, coronary disease, cancer, psychiatric dis- 
orders or other pulmonary disorders were 
excluded from the study. The protocol of the 
study was approved by the Ethical Committee of 
the Medical Faculty of the University of Leiden, 
The Netherlands. 
The GP contacted the selected patients by 
letter. One-hundred and seventy-one patients 
(response rate: 78%) agreed to participate. These 
patients received the QOL questionnaire, 
together with the MRC-ECCS questionnaire 
(30) for anamnestic data, and a questionnaire for 
demographic and further illness severity data. 
Questions regarding illness severity included: 
dyspnoea grade (MRCQ score, part of the 
MRC-ECCS questionnaire); the number of 
attacks of shortness of breath or breathing prob- 
lems in the 14 days preceding the investigation; 
the subjective severity of the breathing problems; 
the number of visits from and to the GP in the 6 
months preceding the investigation; and the 
number of days absent from work in the 12 
months prior to answering the questionnaire. 
Assessment of lung function parameters was not 
possible in this part of the study due to financial 
and logistic reasons. Based on data on anamnes- 
tic variables and symptoms (i.e. age at onset of 
illness, chronic cough, chronic wheeze, smoking 
history, MRCQ score, prescribed medication), 
patients were identified as ‘most probably 
asthma’, ‘most probably COPD’ or ‘diagnosis 
unclear’. 
Concerning the QOL questionnaire, patients 
were asked to answer, on a seven-point Likert 
scale (31) to what degree they had had trouble 
from the specified symptoms and/or com- 
plaints, or to what degree they were impeded 
by their disorder in carrying out specified 
activities. In this phase of developing the ques- 
tionnaire, the authors wanted to identify the 
broad scope of possible consequences of 
CNSLD for the QOL of patients. Therefore, 
the respondents were asked to fill out the ques- 
tionnaire, reflecting possible consequences of 
their disease during the 12 months prior to the 
investigation. 
For the items in the following categories, there 
was a possible answer ‘not applicable’ for per- 
sons who did not pursue such an activity for 
reasons other than having too much trouble 
from breathing problems: general activities; 
daily and domestic activities; sport, hobbies 
and leisure pursuits; social activities; sexuality 
and relationships; profession and work; and 
schooling/training. 
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Upon completion, the questionnaire was 
returned by mail to the research group. The 
returned questionnaires were checked for com- 
pleteness, and in the case of missing information, 
the patient was contacted by telephone. 
STATISTICS 
Data were analysed using the SPSS-PC’ pack- 
age (32). Items of the QOL questionnaire were 
selected for the reduced version of the question- 
naire as follows: 
(1) Items with a ‘not-applicable’ answer cat- 
egory were included in the shortened QOL 
questionnaire if less than 30% of the 
respondents answered ‘not applicable’. 
(2) The inter-item correlations were assessed. If 
an inter-item correlation was O-8 or higher, 
the two items were combined, since items 
which mutually correlate 0.8 or higher give 
little information or variability in the scale 
scores (33). 
(3) Furthermore, for every domain subscale, a 
factor analysis was performed. Items that 
loaded on the first two or three factors of 
each domain subscale were selected for in- 
clusion in the final questionnaire, and again, 
to assure content validity, were grouped into 
domain subscales on the basis of their con- 
tent items. 
After item reduction, Spearman rank (v,) (34) 
correlations between the QOL domain subscales 
as well as between these domain subscales and 
demographic variables were assessed. Internal 
consistency of the QOL domain subscales and 
their reliability was calculated. 
As the ‘not applicable’ answers for the activi- 
ties’ domain subscales were reworded as missing, 
the reliability of these domain subscales was 
determined using the split-half method, in which 
the items were inserted alternately. The reliabil- 
ity of the domain subscales without the ‘not 
applicable’ category was estimated with 
Cronbach’s a coefficient (35,36). 
Spearman rank correlations between the 
domain subscales and demographic and illness 
characteristics were calculated. t-tests (34) were 
used to study possible differences in QOL scores 
between men and women as well as between 
asthma and COPD patients. 
Although it was not the ultimate purpose of 
this phase of the study, the authors tried to get a 
first indication of the construct validity of the 
QOL domain subscales. Therefore, the authors 
studied the correlation of the QOL domain 
subscales and total score with some illness sever- 
ity indicators, as well as the relative importance 
of illness severity variables, background charac- 
teristics and symptoms in explaining QOL, using 
regression analysis. The illness severity indica- 
tors were: the MRCQ score (dyspnoea grade); 
the number of attacks of shortness of breath or 
breathing problems in the 14 days preceding the 
investigation; the subjective severity of the 
breathing problems; the number of visits from 
and to the GP in the 6 months preceding the 
investigation; and the number of days absent 
from work in the 12 months prior to answering 
the questionnaire. 
Background characteristics were: gender, age, 
diagnosis (asthma vs. COPD), duration of illness 
and history of smoking (ever smoked). Symp- 
toms were chronic cough and chronic wheeze 
[MRC-ECCS (30)]. 
LISREL analyses (LISREL-IV package) (37) 
were used to test the goodness of fit of the 
correlations between the QOL domain subscales 
and the illness severity indicators. Univariate 
regression analysis (34) was used to explain the 
relative contribution of the illness and back- 
ground characteristics to total QOL score. 
Results 
PATIENTS 
Of the 38 people (22%) that did not respond to 
the GP’s letter, only gender was known (44% 
male). Of the 171 mailed questionnaires, 155 
were returned, nine of which were unusable, due 
to too many missing data. This reduced the 
number of usable questionnaires to 146, which is 
67% of the group of patients initially selected for 
potential participation in the study. Identifica- 
tion of diagnosis was possible for 130 of these 
patients; 98 were labelled as ‘most probably 
having asthma’ and 32 were labelled as ‘most 
probably having COPD’. For 16 patients, the 
diagnosis was unclear. Background information 
of the total group of 146 patients and of the 
asthma and COPD patients separately, is pre- 
sented in Table 1. 
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TABLE 1. Characteristics of the patients in the study sample 
Total Asthma 
(n= 146) (n=98)* 
COPD 
(n=32)* 
Background characteristics 
Age in years (SD) 40.6 (12.2) 34.8 (10.0) 53.5 (6.3% 
Percentage male ((%I) 40.4 35.7 56.27 
Duration of illness in yr (SD) 14.1 (13.3) 15.0 (13.4) 10.7 (12.5) 
(Ex)smokers (‘%I) 65.1 53.1 90.66 
Visits to GP in last 12 months (SD) 3.7 (4.6) 3.2 (3.2) 6.1 (7.9)‘f. 
Visits to pulmonary physician in last 
12 months (SD) 0.3 (0.7) 0.3 KW 0.6 (0.8)t 
Current medication 
Any pulmonary medicine (‘%) 95.2 96.2 96.9 
Inhalation steroids (“/;I) 51.4 48.9 62,5 
&agonists (%) 46.6 41.8 75.05 
Symptoms 
Chronic cough (o/o) 29.5 19.4 59.43 
Ever wheezing (%) 26.7 26.5 37.5 
Degree of dyspnoea (MRCQ: l-5) (SD) 2.5 (1.4) 2.3 (1.3) 3.4 (1.5)s 
Degree of dyspnoea ~2 (“%I) 33,8 23.5 65.6§ 
*Note that for y1= 16, the diagnosis asthma or COPD was unclear. tP<@05; $P<CbOl; 
gP=o.ooo. 
The mean age of the patient group was almost 
41 years; COPD patients were significantly older 
than asthma patients. Forty percent of the study 
population were male; the COPD group 
consisted of significantly more males than the 
asthma group. 
Almost all the patients (95%) in the study used 
pulmonary medication, and about half of the 
patients used inhalation steroids. &-agonists 
were used by slightly less than half of the 
patients (470/o); this medication was prescribed to 
significantly more COPD patients than asth- 
matic patients (75 vs. 42%). 
Symptoms of chronic cough and wheeze were 
apparent in more than 25%) of the total patient 
group; significantly more COPD patients than 
asthma patients (60 vs. 19(/o) reported com- 
plaints of chronic cough. Also, the degree of 
dyspnoea was significantly higher in COPD 
patients than in asthma patients (3.4 vs. 2.3); the 
mean degree of dyspnoea for the total study 
group was 2.5, reflecting a mild to moderate 
degree of dyspnoea. One-third of the patient 
group reported a degree of dyspnoea higher than 
two. In the group of COPD patients, two-thirds 
of patients had a degree of dyspnoea higher than 
two, whereas in the group of asthma patients, 
less than one-quarter of patients had this grade 
of dyspnoea. 
ITEM REDUCTION 
The first two steps of the selection procedure 
described above (not more than 30% scores of 
‘non-applicability’ for items with this answer 
category, and inter-item correlations of 0.80 or 
more) resulted in a substantial reduction in items 
(a 44 item reduction in Step 1; 18 items trans- 
formed into nine in Step 2). The domain sub- 
scales ‘schooling/training’ and ‘other problems 
related to the treatment of the disease’ were 
applicable to only a minority of the respondents. 
From the subscale ‘profession and work’, only 
some general statements (i.e. being able to do 
one’s daily activities) were applicable to the 
majority of the respondents. The domain sub- 
scales ‘general activities’ and ‘domestic and daily 
activities’ were merged together, as well as the 
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TABLE 2. Spearman rank (rs) correlations between the quality-of-life domain subscales and 
total quality-of-life scale 
A B C D E F G 
A. Breathing problems 1.0 
B. Physical problems 0.68 1.0 
C. Emotions 0.55 0.63 1.0 
D. General activities 0.40 0.55 0.49 1.0 
Situations triggering or enhancing 
E. breathing problems 0.44 0.55 0.49 0.39 1.0 
F. Daily and domestic activities 0.51 0.67 0.54 0.64 0.49 1.0 
Social activities, relationships 
G. and sexuality 0.39 0.48 0.56 0.48 0.51 0.60 1.0 
Quality-of-life for Respiratory Illness 
Questionnaire-total score 0.71 0.84 0.76 0.69 0.74 0.81 0.70 
*All correlations significant at PCO.000. 
domain subscales ‘social activities’ and ‘relation- 
ships and sexuality’. The third step, factor analy- 
sis per domain subscale, selecting the items 
loading on the first two or three factors, resulted 
in a further reduction of the number of items. 
With this three-step selection procedure, the 
questionnaire was reduced from 221 to 55 items, 
with seven domain subscales (see Appendix 1). 
Spear-man rank correlations (34) between the 
domain subscales are presented in Table 2. The 
QOL domain subscales correlated with corre- 
lation coefficients (r,) ranging from 0.39 to 0.68. 
The correlations between the domain subscales 
and the QOL-RIQ total score ranged from 0.69 
to 0.84. All correlations were significant at 
P= O-000. 
From maximum likelihood factor analysis on 
the 55 items of these seven domain subscales, 
only one factor with an eigenvalue greater than 1 
appeared. This factor explained 55% of the vari- 
ance k2=26, df= 14, P<O*O5). So, the seven 
QOL domain subscales share a general QOL 
factor. 
The Spearman rank correlation between the 
QOL-RIQ total score and age was 0.09 
(PzO.33). The correlations between the domain 
subscales and age ranged from - 0.10 to 0.26, 
and were significant for ‘general activities’ 
(r,=0.18; P=O -04) and ‘daily and domestic 
activities’ (r,=O*26); P=O-OOl), reflecting more 
problems on these aspects of daily life for elderly 
patients. 
There was no difference in the QOL-RIQ total 
score between asthmatic and COPD patients. 
However, COPD patients reflected significantly 
more problems in the domain subscale ‘daily and 
domestic activities’ (asthma: 2.4 [mean (M)], 1-l 
[standard deviation (SD)], 2.1 [median (Md)]: 
COPD: 2.9 (M), 1.3 (SD), Md 2.6; t= - 2.47, 
P=O*O2}. This might be explained partly by the 
intercorrelation between the diagnosis ‘COPD’ 
and age. Univariate regression analysis with the 
ranked score of ‘daily and domestic activities’ as 
dependents, and ‘age’ and ‘diagnosis’ as inde- 
pendents shows that ‘age’ explains 6.9% of the 
variance (P=O*OOZ) in this activity domain, 
whereas ‘diagnosis’ explains 4.6% (PzO.2). 
There were no differences between the scores 
for men and women, except in the category 
‘situations and/or substances which trigger or 
enhance breathing problems’. Here, women 
scored higher than men [women: 3.45 (M), 1.3 1 
(SD); mean: 3.00 (M), 1.23 (SD); t= - 2.09, 
P=O.O4]. 
RELIABILITY 
Split-half reliabilities as well as Cronbach’s as of 
the domain subscales and the QOL-RIQ total 
scale are depicted in Table 3. 
Split-half reliabilities were calculated for all 
domain subscales and the QOL-RIQ total scale, 
inserting the items alternately. They vary from 
0.68 to 0.89 for domain subscales; the split-half 
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TABLE 3. Domain subscales, number of items, and reliability per subscale 
Subscale 
Number Split-half Cronbach’s 
of items reliability* a 
A. Breathing problems 9 0.85 0.85 
B. Physical problems 9 0.85 0.84 
C. Emotions 9 0.84 0.88 
D. General activities 4 0.75 - 
Situations triggering or enhancing 
E. breathing problems 7 0.68 - 
F. Daily and domestic activities 10 0.86 - 
Social activities, relationships 
G. and sexuality 7 0.89 - 
Quality-of-life for Respiratory Illness 
Questionnaire-total score 55 0.92 - 
*Items inserted alternately. 
reliability for the QOL-RIQ-total scale is 0.92. 
Cronbach’s a coefficients could only be calcu- 
lated for the three domain subscales without the 
‘not applicable’ answer category, and vary from 
0.84 to 0*88. 
CONSTRUCT VALIDITY: PRELIMINARY 
RESULTS 
Although construct validity of the questionnaire 
is currently being studied in a separate part of 
this project, the authors used it to get a first 
indication of this important requirement of 
newly-developed questionnaires. 
The correlations of the seven QOL domain 
sub-scales with the illness severity indicators 
were determined using Spearman-rank coeffi- 
cients. The correlation coefficient between all 
QOL domain subscales and the combination of 
illness severity indicators was calculated, and the 
relative contribution of several illness severity 
variables, background characteristics and symp- 
toms to the QOL-RIQ total score was studied. 
The correlations between the illness severity 
indicators and the domain subscales ranged 
from r,s=0*23 to r,=0.48 (see Table 4). The 
lowest correlation was between ‘frequency of 
attacks’ and the subscale domain ‘social activi- 
ties, relationships and sexuality’, whereas the 
highest correlations were between ‘visits to the 
GP’ and the subscale domains ‘breathing prob- 
lems’ and ‘daily and domestic activities’. The 
QOL-RIQ total score correlated with the illness 
severity indicators, with rs ranging from 0.45 to 
0.49. The MRCQ score, as well as the subjective 
severity of the breathing problems, had the 
highest correlation with the QOL score. All 
correlations were significant, most of them at the 
P=O*OOO level. 
A canonical correlation coefficient of 0.65 was 
found between the combination of all QOL 
domain subscales (the general QOL), and the 
combination of all illness severity indicators. The 
correlation between the QOL domain subscales 
and the illness severity indicators was also esti- 
mated with a structural equality model (Fig. 1). 
The correlation between the combined compo- 
nent of the QOL domain subscales and that of 
the illness severity indicators is 0.92. This is the 
correlation between the combined set of the 
QOL-RIQ domain subscales and the combined 
set of illness severity indicators, but attenuated 
for the unreliability of all seven QOL domain 
subscales and the illness severity indicators, 
Next, to get an idea of the relative contribu- 
tion of several variables to QOL, univariate 
regression analysis was used with the QOL-RIQ 
total score as dependent variable. Data on illness 
severity, background characteristics and symp- 
toms were used as independent variables. The 
results of this analysis are presented in Table 5. 
The independent variables are grouped into 
these three categories, and listed in order of 
relative contribution to the total QOL score. 
From Table 5, it can be concluded that illness 
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TABLE 4. Spearman rank correlations of the quality-of-life domain subscales, Quality-of-Life for Respiratory 
Illness Questionnaire (QOL-RIQ) total score and indicators of illness severity 
Illness severity 
indicators 
Degree of 
dyspnoea Frequency Subjective Visits Absence 
MRCQ of attacks severity to GP from work 
Quality of life domain subscales 
A. Breathing problems 
B. Physical problems 
C. Emotions 
D. General activities 
Situations triggering or enhancing 
E. breathing problems 
F. Daily and domestic activities 
Social activities, relationships 
G. and sexuality 
QOL-RIQ-total score 
0.34? 0.32? 0.34T 0.48? 0.40t 
0.41t 0.397 0.41t 0.40t 0.41? 
O-33? 0.3oj- 0.33t 0.34t 0.40t 
0.40t 0.317 o-407 0.26* o-31* 
0.41t 0.337 0.41f- 0.27* 0.32* 
0.40t 0.357 o-407 0.487 0.29” 
0.30t 0.23* 0*3oy 0.43? 0.31* 
0.497 0.457 0.49? 0.47? 0.46? 
*PIo-01; tP=o.ooo. 
severity variables, and especially the more 
subjective variable ‘severity of breathing prob- 
lems’, explain the highest proportion of the 
variance in the QOL score (with P<O*OOO); 
subjective severity of breathing problems 
explains about 25% of the variance in QOL. The 
contribution of the MRCQ score is also quite 
substantial; 17.5% of variance in QOL score is 
explained by grade of dyspnoea. The contribu- 
tion of the other illness severity variables is 
somewhat less proportional-absence from 
work, 17%; frequency of attacks, c. 13%; visits 
to GP, c. 10% -but still more than the con- 
tribution of background characteristics and 
symptoms. The influence of background charac- 
teristics such as age, gender and diagnosis is 
neglectable (ranging from 0.9 to 1.7, not signifi- 
cant). Of the ‘symptoms’, chronic wheeze and 
chronic cough explain almost 10 and 8%, 
respectively, of the QOL score. Smoking history 
as well as duration of illness do not contribute to 
the QOL-RIQ total score. 
Discussion and Conclusions 
Through this investigation, a disease-specific 
QOL questionnaire for mild to moderately 
severe CNSLD patients (the QOL-RIQ) has 
Breathing problems r = 0.75 
Physical problems r = 0.82 
Emotions r = 0.64 
General activities r = 0.71 
Situations r = 0.66 Quality of life -r = 092 - 
Daily and domestic r = 0.83 
activities 
Social activities, r = 0.75 
relationships and 
sexuality 
Grade of 
dyspnoea 
Frequency of 
attacks 
Visits to GP 
\ 
r = 0.65 Absence fmm 
work 
J 
FIG. 1. Model of the correlation between the combined components of the quality-of-life domain subscales 
and illness severity indicators. 
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TABLE 5. Univariate regression analysis with ranked Quality-of-Life for Respiratory Illness 
Questionnaire (QOL-RIQ) total score as dependent 
QOL-RIQ total score 
Independent variables 
Explained 
variance (0%) Sign 
Illness severity 
Subjective severity of attacks 
Grade of dyspnoea (MRCQ score) 
Absence from work 
Frequency of attacks 
Visits to GP 
Background characteristics 
Gender 
Diagnosis (asthma W. COPD) 
Age 
Ever smoked 
Duration of illness 
Symptoms* 
Chronic wheeze 
Chronic cough 
25.3 0.000 
17.5 0.000 
16.5 0.000 
12.8 0.000 
10.3 0.000 
1.7 ns 
1.3 ns 
0.9 ns 
0.9 ns 
0.5 ns 
9.8 0.000 
7.9 0.001 
*Diagnosis is partly based on these symptoms. COPD, chronic obstructive pulmonary 
disease; ns, not significant. 
been developed, which contains 55 items, in 
seven areas of daily life. The internal reliability 
of the total questionnaire as well as of its domain 
subscales is quite satisfactory. The seven domain 
subscales address a broad scope of aspects of 
daily functioning which can be limited due to 
chronic respiratory illness. Also, they represent 
the three areas of daily life that should always be 
included in QOL questionnaires: physical and 
functional status, psychological status and social 
functioning. 
The QOL-RIQ total score was not correlated 
with age, nor was there a difference between 
asthma or COPD patients. This indicates that 
the questionnaire can be used for both of these 
patient groups, as well as for broad age groups. 
Caution has to be taken with some domain 
subscale scores; in particular, ‘daily and domes- 
tic activities’ seems to reflect more problems in 
elderly than in younger patients. The domain 
subscale ‘situations triggering or enhancing 
breathing problems’ seems to reflect more 
problems in women than in men. This will be 
studied in more detail in the next phase of the 
project. 
The preliminary results on the construct valid- 
ity show significant correlations between QOL 
and several illness severity variables. Most of 
these illness severity data are rather subjective, 
reflecting patients’ experiences. A more objective 
illness severity variable is the MRCQ score, 
reflecting the degree of dyspnoea, based on 
activities patients are able or unable to perform. 
Both the MRCQ score and the subjective sever- 
ity of breathing problems showed the strongest 
correlation with the QOL-RIQ total score. 
Results of regression analysis also showed the 
importance of these two variables in contribut- 
ing to the QOL-RIQ total score. The more or 
less subjective illness severity variables were the 
most profound predictors of the QOL score. 
Symptoms such as chronic cough and wheeze 
explained only small parts of the total QOL 
score. Background characteristics (age, gender, 
diagnosis, smoking history, duration of illness) 
did not contribute significantly to QOL score. It 
appears that the illness severity indicators used, 
give, in the main, a reflection of the subjective 
experiences of the severity of the illness. How- 
ever, it has to be noted that this needs to be 
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studied in more detail in the second phase of the 
study, in which the validity of the questionnaire 
will be tested. 
Quality-of-life research in asthma and COPD 
patients has been a somewhat underdeveloped 
area for a long period of time. Recently, 
however, several research groups have started to 
study this topic in more detail. As a result, 
several disease-specific questionnaires assessing 
QOL have been developed, most of them in the 
nineties, and have already been reviewed in 
detail (17,23,38,39). 
Currently, six questionnaires are available in 
English which measure the disease-specific 
QOL in CNSLD patients (8,33,40-46). In 
essence, it can be concluded that definitions of 
QOL are mostly lacking, which seems to be a 
consequence of the absence of a straightfor- 
ward theory of QOL (17,23,39). Due to this, 
some questionnaires contain only a limited 
number of areas of daily life which can be 
influenced by the disorder (8,45). The ‘Living 
with Asthma Questionnaire’ (40,41) and the 
‘Asthma Quality-of-Life Questionnaire’ (46) are 
two measures which illuminate the physical and 
functional status as well as the psychological 
and social functioning of the patient. The ‘Life 
Activities Questionnaire for Adult Asthma’ 
(LAQAA) (44) is not defined by the authors as 
a QOL scale in itself, but can be used as a 
component of a battery of QOL instruments. 
However, it concerns activities in seven cat- 
egories of daily life, which can be restricted or 
changed due to asthma. 
Concerning the patient groups for which these 
questionnaires are meant, it seems that most of 
them are applicable for moderate to severe asth- 
matic and/or COPD patients (8,4043,46). In 
developing the ‘Living With Asthma Question- 
naire’, Hyland (40,41) addressed patients in 
general practice settings, probably reflecting 
mild to moderate illness severity. The question- 
naire seems to be focussing on asthmatic patients 
only. 
The construction of domain subscales in the 
QOL-RIQ, to achieve content validity, is in 
accordance with the way most QOL question- 
naires are constructed (29,38,47). The fact that 
different scales have different types and numbers 
of subscales is a reflection of the different con- 
cepts of QOL that authors have (29). 
The uni-dimensionality of the questionnaire 
reflects the general underlying QOL factor which 
is shared by the domain subscales. This is in 
accordance with the results of Hyland, who also 
developed an uni-dimensional QOL question- 
naire for asthma patients, which consisted of 11 
domain subscales (40,41). 
It has to be mentioned that the QOL question- 
naire and the illness severity questions reflected 
different periods of time; in this scale construc- 
tion phase, the QOL questions regarded a period 
of 12 months, whereas questions on illness sever- 
ity regarded periods of 2 weeks, 3 months or 12 
months. This urges one to take caution when 
making strong conclusions based on these 
results. 
In general, lung function parameters are 
regarded as the most objective for assessing 
illness severity in asthma and COPD patients. 
In the literature, some studies do show 
correlations between QOL and physiological 
measures (48,49); however, others do not at all 
(50-52). If present, these correlations are, in 
general, not strong (53). It seems that relation- 
ships between QOL in respiratory illness and 
spirometry is stronger when the QOL question- 
naire used assesses mainly [or sometimes 
only (49)] the physical component of daily 
functioning (17). In general, lung function par- 
ameters do not influence QOL, indicating 
that this is something different than a straight- 
forward reflection of ‘objective’ disease 
severity (17). 
The questionnaire developed in this study is, 
in its present form, meant for asthmatic 
patients as well as people with COPD in gen- 
eral practice, reflecting mild to moderate 
disease severity. It covers a broad range of 
aspects from daily life, which is necessary 
for a QOL questionnaire. Apart from 
research purposes, it can be used in clinical 
practice for diagnosis and for examination. At 
this time, the validity of the developed ques- 
tionnaire is being further examined, in- 
cluding responsiveness to change and test- 
retest reliability. Also, the relationship of 
QOL with individuals’ characteristics and ill- 
ness severity-including spirometry-is being 
studied, and its reliability and applicability in 
outpatient and rehabilitation populations is 
being tested. 
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Appendix 1: Items of the Quality-of-Life 
for Respiratory Illness Questionnaire 
(QOL-RIQ)* 
A. BREATHING PROBLEMS 
(I) Difficulty breathing in; 
(2) Wheezing; 
(3) Heavy breathing; 
(4) Chest tightness with shortness of breath; 
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(5) An itchy throat; 
(6) The need to clear your throat frequently; 
(7) Coughing; 
(8) Recurrent colds; 
(9) A stuffed up nose. 
B. PHYSICAL PROBLEMS RELATED TO CHEST 
PROBLEMS 
(1) 
(2) 
(3) 
(4) 
(5) 
(61 
(7) 
(8) 
(9) 
Sleeping limbs; 
Pins and needles; 
Feeling your heart is racing; 
Tiredness; 
Exhaustion; 
Waking up in the morning with breathing 
symptoms; 
The need to rest frequently during the day; 
Waking up in the night or early in the 
morning because of breathing problems; 
Poor appetite. 
C. EMOTIONS RELATED TO CHEST PROBLEMS 
(1) 
(79 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
(9) 
Worried about my breathing problems; 
Puzzled about my breathing problems; 
Concerned about the future consequences 
of my breathing problems; 
Down in the dumps, depressed; 
Restless, nervous; 
Short-tempered, impatient with others; 
Moody; 
Feeling dependent upon others; 
Upset by too much sympathy of others. 
D. PROBLEMS WITH GENERAL ACTIVITIES 
(1) Being unable to do one’s daily activities; 
(2) Problems with ‘getting started’ in the morn- 
ing because of chest problems; 
(3) Less pleasure in one’s daily activities due to 
chest problems; 
(4) Problems with doing hobbies. 
E. SITUATIONS THAT MIGHT TRIGGER OR 
ENHANCE BREATHING PROBLEMS 
(1) Being in air-conditioned buildings; 
(2) Being outside on cold days; 
(3) Being outside on foggy days; 
(4) Being outside on humid days; 
(5) Being outside during the pollen season; 
(6) Due to domestic animals or pets; 
(7) By flowers, trees, plants. 
F. DAILY AND DOMESTIC ACTIVITIES 
(1) Going upstairs; 
(2) 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
(9) 
(10) 
Running a short distance; 
Cycling; 
Lifting a heavy object; 
Going to the toilet; 
Taking a bath/shower and/or getting 
dressed; 
Washing yourself; 
Polishing; 
Looking after the family; 
Shopping. 
G. SOCIAL ACTIVITIES, RELATIONSHIPS AND 
SEXUALITY 
(1) Going out for a day-trip; 
(2) Going to (birthday) parties; 
(3) Visiting friends and relatives; 
(4) Having difficulties with cuddling and kiss- 
ing; 
(5) Having no sexual desire due to chest prob- 
lems; 
(6) Having difficulties with sexual intercourse 
due to chest problems; 
(7) Being too tired to have sexual intercourse 
due to chest problems. 
*The complete questionnaire, including instruc- 
tion, can be requested from the authors. 
